4oka - Revision history

OCA at 14:56, 8 November 2023

OCA — Wed, 08 Nov 2023 14:56:38 GMT

←Older revision		Revision as of 14:56, 8 November 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptomyces_avidinii Streptomyces avidinii]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4OKA FirstGlance]. <br>		<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptomyces_avidinii Streptomyces avidinii]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4OKA FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.505Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [https://pdbe.org/4oka PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [https://www.ebi.ac.uk/pdbsum/4oka PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [https://pdbe.org/4oka PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [https://www.ebi.ac.uk/pdbsum/4oka PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>
	</table>		</table>

OCA at 07:29, 25 January 2023

OCA — Wed, 25 Jan 2023 07:29:56 GMT

←Older revision		Revision as of 07:29, 25 January 2023
Line 3:		Line 3:
	<StructureSection load='4oka' size='340' side='right'caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>		<StructureSection load='4oka' size='340' side='right'caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~As_4.1583 As 4.1583~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4OKA FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptomyces_avidinii Streptomyces avidinii]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4OKA FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [~~http~~://pdbe.org/4oka PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4oka PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [https://pdbe.org/4oka PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [https://www.ebi.ac.uk/pdbsum/4oka PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/SAV_STRAV SAV_STRAV]] The biological function of streptavidin is not known. Forms a strong non-covalent specific complex with biotin (one molecule of biotin per subunit of streptavidin).	+	[https://www.uniprot.org/uniprot/SAV_STRAV SAV_STRAV] The biological function of streptavidin is not known. Forms a strong non-covalent specific complex with biotin (one molecule of biotin per subunit of streptavidin).
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 25:		Line 25:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: As 4 1583]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Heinisch, T~~]]	+	[[Category: Streptomyces avidinii]]
-	[[Category: ~~Schirmer,~~ T]]	+	[[Category: Heinisch T]]
-	[[Category: ~~Beta barrel]]~~	+	[[Category: Schirmer T]]
-	~~[[Category: Biotin-binding protein]]~~	+
-	~~[[Category: Iridium piano stool]]~~	+
-	~~[[Category: Transfer hydrogenation~~]]	+

OCA at 07:59, 17 April 2019

OCA — Wed, 17 Apr 2019 07:59:38 GMT

←Older revision		Revision as of 07:59, 17 April 2019
Line 1:		Line 1:

	==Structural-, Kinetic- and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis==		==Structural-, Kinetic- and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis==
-	<StructureSection load='4oka' size='340' side='right' caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>	+	<StructureSection load='4oka' size='340' side='right'caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OKA FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/As_4.1583 As 4.1583]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OKA FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://pdbe.org/4oka PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://pdbe.org/4oka PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>
Line 18:		Line 18:
	</div>		</div>
	<div class="pdbe-citations 4oka" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 4oka" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Avidin 3D structures\|Avidin 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: As 4 1583]]
		+	[[Category: Large Structures]]
	[[Category: Heinisch, T]]		[[Category: Heinisch, T]]
	[[Category: Schirmer, T]]		[[Category: Schirmer, T]]

OCA at 11:40, 4 August 2016

OCA — Thu, 04 Aug 2016 11:40:39 GMT

←Older revision		Revision as of 11:40, 4 August 2016
Line 1:		Line 1:
		+
	==Structural-, Kinetic- and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis==		==Structural-, Kinetic- and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis==
	<StructureSection load='4oka' size='340' side='right' caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>		<StructureSection load='4oka' size='340' side='right' caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>
Line 4:		Line 5:
	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OKA FirstGlance]. <br>		<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OKA FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://pdbe.org/4oka PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4oka ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4oka" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 08:56, 25 December 2014

OCA — Thu, 25 Dec 2014 08:56:43 GMT

←Older revision		Revision as of 08:56, 25 December 2014
Line 6:		Line 6:
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/SAV_STRAV SAV_STRAV]] The biological function of streptavidin is not known. Forms a strong non-covalent specific complex with biotin (one molecule of biotin per subunit of streptavidin).
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==

OCA at 07:48, 3 December 2014

OCA — Wed, 03 Dec 2014 07:48:18 GMT

←Older revision		Revision as of 07:48, 3 December 2014
Line 18:		Line 18:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: Heinisch, T.]]	+	[[Category: Heinisch, T]]
-	[[Category: Schirmer, T.]]	+	[[Category: Schirmer, T]]
	[[Category: Beta barrel]]		[[Category: Beta barrel]]
	[[Category: Biotin-binding protein]]		[[Category: Biotin-binding protein]]
	[[Category: Iridium piano stool]]		[[Category: Iridium piano stool]]
	[[Category: Transfer hydrogenation]]		[[Category: Transfer hydrogenation]]

OCA at 08:49, 5 November 2014

OCA — Wed, 05 Nov 2014 08:49:43 GMT

←Older revision		Revision as of 08:49, 5 November 2014
Line 1:		Line 1:
-	'''~~Unreleased~~ structure'''	+	==Structural-, Kinetic- and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis==
		+	<StructureSection load='4oka' size='340' side='right' caption='[[4oka]], [[Resolution\|resolution]] 2.50Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4oka]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OKA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OKA FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5IR:[N-(4-{[2-(AMINO-KAPPAN)ETHYL]SULFAMOYL-KAPPAN}PHENYL)-5-(2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTANAMIDATO]IRIDIUM(III)'>5IR</scene>, <scene name='pdbligand=IR:IRIDIUM+ION'>IR</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oka FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oka OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oka RCSB], [http://www.ebi.ac.uk/pdbsum/4oka PDBsum]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	An artificial imine reductase results upon incorporation of a biotinylated CpIr moiety (Cp = C5Me5-) within homotetrameric streptavidin (Sav) (referred to as CpIr(Biot-p-L)Cl] subset Sav). Mutation of S112 reveals a marked effect of the Ir/streptavidin ratio on both the saturation kinetics as well as the enantioselectivity for the production of salsolidine. For [CpIr(Biot-p-L)Cl] subset S112A Sav, both the reaction rate and the selectivity (up to 96% ee (R)-salsolidine, kcat 14-4 min-1 vs [Ir], KM 65-370 mM) decrease upon fully saturating all biotin binding sites (the ee varying between 96% ee and 45% ee R). In contrast, for [Cp*Ir(Biot-p-L)Cl] subset S112K Sav, both the rate and the selectivity remain nearly constant upon varying the Ir/streptavidin ratio [up to 78% ee (S)-salsolidine, kcat 2.6 min-1, KM 95 mM]. X-ray analysis complemented with docking studies highlight a marked preference of the S112A and S112K Sav mutants for the SIr and RIr enantiomeric forms of the cofactor, respectively. Combining both docking and saturation kinetic studies led to the formulation of an enantioselection mechanism relying on an "induced lock-and-key" hypothesis: the host protein dictates the configuration of the biotinylated Ir-cofactor which, in turn, by and large determines the enantioselectivity of the imine reductase.

-	~~The entry 4oka is ON HOLD until Paper Publication~~	+	Structural, Kinetic, and Docking Studies of Artificial Imine Reductases Based on Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis.,Robles VM, Durrenberger M, Heinisch T, Lledos A, Schirmer T, Ward TR, Marechal JD J Am Chem Soc. 2014 Oct 28. PMID:25317660<ref>PMID:25317660</ref>

-	~~Authors~~: ~~Schirmer~~, T.~~, Heinisch~~, T.	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~Description~~: ~~Structural-, Kinetic-and Docking Studies of Artificial Imine Reductases Based on the~~ Biotin-~~Streptavidin Technology~~: ~~An Induced Lock-and-Key Hypothesis~~	+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Heinisch, T.]]
		+	[[Category: Schirmer, T.]]
		+	[[Category: Beta barrel]]
		+	[[Category: Biotin-binding protein]]
		+	[[Category: Iridium piano stool]]
		+	[[Category: Transfer hydrogenation]]

OCA at 04:51, 13 February 2014

OCA — Thu, 13 Feb 2014 04:51:01 GMT

←Older revision		Revision as of 04:51, 13 February 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4oka is ON HOLD	+	The entry 4oka is ON HOLD until Paper Publication

	Authors: Schirmer, T., Heinisch, T.		Authors: Schirmer, T., Heinisch, T.

	Description: Structural-, Kinetic-and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis		Description: Structural-, Kinetic-and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis

OCA at 10:30, 5 February 2014

OCA — Wed, 05 Feb 2014 10:30:42 GMT

←Older revision		Revision as of 10:30, 5 February 2014
Line 5:		Line 5:
	Authors: Schirmer, T., Heinisch, T.		Authors: Schirmer, T., Heinisch, T.

-	Description: ~~fs24 up7~~ Structural-, Kinetic-and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis ~~f1�fs32 f0�0fs26 up0~~	+	Description: Structural-, Kinetic-and Docking Studies of Artificial Imine Reductases Based on the Biotin-Streptavidin Technology: An Induced Lock-and-Key Hypothesis

OCA: Protected "4oka" [edit=sysop:move=sysop]

OCA — Wed, 29 Jan 2014 07:11:48 GMT

Protected "4oka" [edit=sysop:move=sysop]

←Older revision

Revision as of 07:11, 29 January 2014